Author:
Kaur Amritpal,Sharma Yash,Kumar Anoop,Ghosh Madhumita P.,Bala Kumud
Abstract
AbstractAbrus precatorius is a tropical medicinal plant with multiple medicinal benefits whose seeds have not yet been studied against cervical cancer. Herein, we have assessed the antioxidant and antiproliferative properties of seed extracts (ethyl acetate and 70% ethanol) prepared from Soxhlet and Maceration extraction methods against Hep2C and HeLa Cells. We observed that the APE (Sox) extract had a significantly higher total flavonoid content, APA (Mac) extract had a high total phenolic content, and APA (Sox) extract had a high total tannin content. Further, HPLC analysis of extracts revealed the presence of tannic acid and rutin. Moreover, APA (Sox) exhibited the highest free radical scavenging activity. APE (Mac) had the best antiproliferative activity against Hep2C cells, while APA (Sox) had the best antiproliferative activity against HeLa cells. In Hep2C cells, APE (Mac) extract revealed the highest SOD, catalase activity, GSH content, and the lowest MDA content, whereas APA (Mac) extract demonstrated the highest GST activity. In HeLa cells, APA (Sox) extract showed the highest SOD, GST activity, GSH content, and the least MDA content, whereas APA (Mac) extract showed the highest catalase activity. Lastly, docking results suggested maximum binding affinity of tannic acid with HER2 and GCR receptors. This study provides evidence that A. precatorius seed extracts possess promising bioactive compounds with probable anticancer and antioxidant properties against cervical cancer for restricting tumor growth.
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J. Clin. 71, 209–249 (2021).
2. Safaeian, M., Solomon, D. & Castle, P. E. Cervical cancer prevention-cervical screening: science in evolution. Obstet. Gynecol. Clin. North Am. 34, 739–760 (2007).
3. Yoshida, K. et al. The upregulated expression of vascular endothelial growth factor in surgically treated patients with recurrent/radioresistant cervical cancer of the uterus. Oncol. Lett. 16, 515–521 (2018).
4. Gutiérrez-Hoya, A. et al. Cervical cancer cells express markers associated with immunosurveillance. J. Immunol. Res. 2019, 1 (2019).
5. Kost, B. P. et al. Glucocorticoid receptor in cervical cancer: an immunhistochemical analysis. Arch. Gynecol. Obstet. 299, 203–209 (2019).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献